Clinical Trials Logo

Filter by:
NCT ID: NCT05805072 Not yet recruiting - Clinical trials for Relapsed/Refractory AML

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of selinexor and HAAG +/- HMA in relapsed/refractory acute leukemia (AML) patients.

NCT ID: NCT05805007 Recruiting - Clinical trials for Retinitis Pigmentosa

Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa

Start date: September 12, 2023
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and efficacy of a single escalating doses of ZVS203e administered via subretinal injection in participants with RP caused by RHO site-specific gene mutation (RHO-RP).

NCT ID: NCT05804942 Recruiting - Healthy Clinical Trials

Metabolic Response to Variations in Dietary Glycemic Index

Start date: April 13, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to compare metabolic response to variations in dietary glycemic index in healthy participants. The main questions it aims to answer are: • What are the metabolic hunger and food intake responses to different levels of glycemic index on the background of otherwise constant macronutrient composition? Participants will come to the lab after an overnight fast and body composition will be tested by bio-impedance analysis and magnetic resonance imaging. They will then be randomized to eat one of three standardized breakfasts varying in the glycemic index. Circulating glucose levels will be monitored using a continuous glucose monitor and blood samples will be collected to measure metabolic and hormone factors in the serum. Participants will also rate their hunger at 0, 30, 60, 120, 180, 240 and 300 minutes. After 5 hours they will eat a free choice meal from a standardized selection buffet (test meal).

NCT ID: NCT05804929 Recruiting - Health Behavior Clinical Trials

Phenotypic Characteristics of Superlean Individuals Including Gut Microbiome

Start date: April 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to build on our previous work to further characterise the phenotype of superlean individuals (BMI < 18.5) when compared to normal BMI people (BMI 21.5 to 25). This will include characterising the body composition, food intake behaviour, circulating hormone levels, genetics and characteristics of the gut microbiota. The investigators expect to recruit up to 200 healthy superlean and control volunteers respectively,

NCT ID: NCT05804916 Recruiting - Breast Cancer Clinical Trials

Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer

Start date: April 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This study is a single-center,blinded, efficacious, phase III randomized clinical trial initiated by investigators. The primary objective is to investigate the use of Surface Guided Radiation Therapy (SGRT) in combination with Deep Inspiration Breath Hold (DIBH) technique for left breast cancer treatment, compared to traditional laser alignment with free breathing treatment. This approach offers superior positioning accuracy and improved heart protection without any increase in radiation or adverse reactions.

NCT ID: NCT05804864 Not yet recruiting - Clinical trials for Advanced Solid Tumors

A Study of KM501 in Patients With Solid Tumors

Start date: April 2023
Phase: Phase 1
Study type: Interventional

A single-arm, open, multicenter Phase I study to evaluate the safety, tolerability, pharmacokinetic profile, and efficacy of the KM501 double-antibody ADC in subjects with advanced solid tumors that express, amplify, or mutate HER2

NCT ID: NCT05804851 Active, not recruiting - Skin Microbiome Clinical Trials

Skin Microbiome of Chinese Population Cohort Study

Start date: May 8, 2023
Phase:
Study type: Observational [Patient Registry]

This observational study aims to investigate the relationship between public health and the skin microbiome in the province of Zhejiang. Due to the lack of current research on the skin microbiome, the following general questions will be investigated in this study: 1) What connection exists between dietary practices and facial skin microbiome? 2) How do people's lifestyle routines affect the facial skin microbiome? 3) What effects does the altered living environment have on people's facial skin microbiomes? 4) How do the seasons affect people's facial skin microbiomes? Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.

NCT ID: NCT05804539 Completed - Clinical trials for Forward Head Posture

The Recovering Strategy on Forward Head Posture in Chinese Adolescents: Tai Chi and Manual Therapy

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Forward head posture (FHP) is a prevalent deformity that can cause various health issues in adolescents. The programs combining manual therapy (MT) and stability exercises (SE) have shown better effectiveness than stability exercises and home exercises in recovering FHP. However, the effectiveness of the therapy program consisting of Tai Chi and MT for recovering FHP remains unclear. Therefore, this study aimed to investigate the effects of Tai Chi with MT on FHP recovery. Meanwhile, with a particular focus on personalized medicine, we utilized explainable artificial intelligence (XAI) to predict if individuals would reverse to healthy posture based on different interventions.

NCT ID: NCT05804526 Recruiting - Clinical trials for Advanced Solid Tumours

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

Start date: July 19, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate safety , clinical pharmacology and efficacy of intravenous RC88 combined with Sintilimab in advancedsolid tumours

NCT ID: NCT05804474 Completed - Clinical trials for Intracranial Aneurysm

A Retrospective, Multicenter, Controlled Clinical Trail: to Evaluate the Clinical Efficiency of Intracranial Aneurysm Assistive Software in the Morphological Measurement

Start date: January 1, 2021
Phase:
Study type: Observational

the goal of this clinical trail is to evaluate the clinical efficiency of intracranial aneurysm assistive software in the morphological measurement. The trail is designed as retrospective, multicenter, controlled clinical trail. Collecting probable cases images retrospectively according to inclusion criteria and exclusion criteria strictly. Controlling bias strictly, to make sure the measurement of intracranial aneurysm assistive software is evaluated reliably and precisely. In our trail, six physicions were recruited, containing three neuroradiologists, two radiologists and a residents. Software-assistant planning controls against no software-assisant planning,which aims to evaluate the improvement of morphological measurement efficiency of physicians.